http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107099589-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
filingDate | 2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107099589-B |
titleOfInvention | Application of LncRNA ZNF503-AS1 in the preparation of kits for diagnosing retinal degenerative diseases |
abstract | The invention discloses the application of LncRNA ZNF503-AS1 in preparing a kit for diagnosing retinal degenerative diseases. The application of a reagent for detecting the expression level of LncRNA ZNF503-AS1 in the preparation of a kit for diagnosing retinal degenerative diseases. Application of LncRNA ZNF503‑AS1 in the preparation of drugs for treating retinal degenerative diseases. We found that the decreased expression of LncRNA ZNF503‑AS1 can be used as an auxiliary diagnostic basis for retinal degenerative diseases, helping to achieve early diagnosis of retinal degenerative diseases. The protective effect of LncRNA ZNF503‑AS1 on the retina suggests that it can be used to prepare and screen drugs for the treatment of retinal degenerative diseases. The present invention provides new detection markers and therapeutic targets for retinal degenerative diseases, and provides brand-new molecular information and biological basis for the diagnosis and treatment of the diseases. |
priorityDate | 2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.